Bb. Lonsberry et al., EFFECT OF HIGH-DOSE VERAPAMIL ADMINISTRATION ON THE CA2+ CHANNEL DENSITY IN RAT CARDIAC TISSUE, Pharmacology, 49(1), 1994, pp. 23-32
It is well known that beta-adrenergic receptors will down-regulate in
the presence of high circulating levels of beta-adrenergic agonists ov
er extended periods of time. However, less is known with respect to th
e effect of Ca2+ channel antagonists on their receptors. The purpose o
f this study was to determine if chronic administration of high dosage
s of verapamil (in the toxic range) could alter the density of Ca2+ ch
annels in the heart as determined by [H-3]PN 200-110 binding. A range
of high verapamil concentrations was administered to rats via s.c. imp
lantable slow-release pellets or s.c. injection. An increasing rate of
mortality was observed as the dose of verapamil administered increase
d. Quantitation of serum verapamil concentrations demonstrated that th
e s.c. slow release implantable pellets were not releasing the drug ev
enly and instead released toxic quantities of drug during the first 24
h after implantation. Serum verapamil levels determined from verapami
l-injected animals demonstrated a dose-dependent increase in circulati
ng levels. No significant alterations in Ca2+ channel characteristics
(B-max and K-d) were noted in cardiac tissue obtained from either trea
tment regime. Our results demonstrate that implantable pellets are not
a reliable administration method for verapamil and cardiac Ca2+ chann
els are unusually resistant to biochemical alterations even after admi
nistration of verapamil dosages in the toxic range.